Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

oral path 2, exam 2 > Lymphoreticular disorders > Flashcards

Lymphoreticular disorders Flashcards

1
Q

_____________ are considered to be a group of related disorders caused by proliferation of Langerhans cells

A

Langerhans Cell Histiocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

T/F: Langerhans cells are related to monocytes and serve as antigen-presenting cells

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the 3 clinical presentations of Langerhans cell Histiocytosis?

A

1) Acute disseminated histiocytosis
2) Chronic disseminated histiocytosis
3) Eosinophilic granuloma, which may be monostotic or polyostotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what form of Langerhans Cell Histiocytosis is seen only in infants?

what are its symptoms?

A

Acute disseminated histiocytosis

  • Skin rash, splenic and hepatic involvement
  • Usually a very aggressive, malignant course
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what form of Langerhans cell histiocytosis is found in older children?

A

Chronic disseminated histiocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the symptoms of Chronic disseminated histiocytosis?

A

Classic triad of:

1) exophthalmos
2) diabetes insipidus
3) bone lesions (well-defined radiolucencies) is actually rather uncommon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Eosinophilic granuloma of bone affects what age groups?

A

Teenagers and adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the 2 types clinical forms of Eosinophilic granulomas?

what is the radiographic presentation/appearance?

A
  • May be polyostotic (teenagers) or monostotic (older adults)
  • Well-defined, but non-corticated radiolucency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the Histopathologic Features of Langerhans cell histiocytosis?

A

Sheets of large, histiocytic-appearing cells (neoplastic Langerhans cells)

Variable numbers of eosinophils (“eosinophilic granuloma”)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the treatment options for Langerhans cell histiocytosis?

A

Acute – chemotherapy; poor prognosis

Chronic – radiation and/or chemotherapy; guarded prognosis

Eosinophilic granuloma – curettage or radiation; good prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

___________ are a group of hematologic malignancies characterized by tumor cells circulating in the blood

A

Leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how is Leukemia classified/categorized?

A

A) Broadly divided into lymphocytic and myelomonocytic types

B) Further divided into acute and chronic forms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the symptoms of Leukemia?

A

A) Patients often present with signs and symptoms related to myelophthisic anemia (normal bone marrow cells replaced by leukemic cells)

B) Fatigue, SOB, pallor (decreased RBC’s)

C) Easy bruising (decreased platelets)

D) Infection (decreased WBC’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Oral involvement of Leukemia is most frequently seen in the ________________ forms

A

myelomonocytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what lesion forms in the oral cavity as a result of Leukemia?

A

“granulocytic sarcoma”

A) Focal mass of leukemic cells may develop at one soft tissue site – “granulocytic sarcoma”

B) Diffuse gingival enlargement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how is leukemia diagnosed?

A

1) This diagnosis is usually based on finding increased numbers of atypical WBC’s in the circulation
2) Type of leukemia is determined by immunohistochemical/cytogenetic studies
3) If gingival enlargement caused by leukemia is biopsied, atypical cells can be characterized

17
Q

Treatment options for Leukemia:

A

Chemotherapy

Bone marrow or stem cell transplantation

Targeted gene therapy – experimental, but promising

18
Q

_________ are malignancies of Lymphoid cells

A

Lymphoma

19
Q

how are Lymphomas classified?

A

Usually divided into Hodgkin and non-Hodgkin forms

1) Hodgkin lymphoma develops in the lymph nodes
2) Non-Hodgkin lymphoma may develop in nodes, soft tissue or bone

20
Q

what age group/groups are at risk for Hodgkins Lymphomas

A

Bimodal age distribution:
2nd-3rd decades and > 50 yrs old
~9,000 cases in US in 2015

21
Q

what are the clinical features/characteristics of Hodgkins Lymphoma?

A

Head and neck is common site of initial involvement

One or more rubbery-firm, enlarging, painless lymphadenopathy (cervical, supraclavicular)

22
Q

Hodgkins Lymphoma treatment and prognosis:

give for both low and high stages

A

Based primarily on stage
1) Low stage (localized disease)
Chemotherapy and radiotherapy, ~100% 5 yr survival

2) High Stage (widespread disease)
Chemotherapy; 50% 5 yr survival

23
Q

T/F: Non-Hodgkins lymphoma Generally effects an older age group of patients than with Hodgkin lymphoma

A

True

24
Q

Characteristics of Non-Hodgkins Lymphoma:

how many new cases per year, where they occur

A

71,000 cases in US in 2015

Most present in the lymph nodes, but 30-40% are extra nodal

25
Q

what are the oral presentations of Non-Hodgkins Lymphoma? What are the radiographic findings?

A

1) Oral involvement of soft tissue is usually seen as a diffuse mass of the soft palate or the buccal vestibule
2) Mandibular involvement may be associated with “numb chin” sign
3) “Moth-eaten” or ill-defined radiolucency seen radiographically

26
Q

what is the treatment for Lymphomas?

A

Localized disease – radiation therapy, with or without chemotherapy

More generalized disease – multi-agent chemotherapy

27
Q

Prognosis For Hodgkins, and Non-Hodgkins lymphomas:

A

Hodgkin lymphoma – good, with many series reporting a 95% 10-year survival rate, especially with low-stage disease

Non-Hodgkin lymphoma- much more variable prognosis, depends on the type, grade and stage of disease

28
Q

what is the definition of “Plasmacytoma/Multiple Myeloma”?

A

Neoplastic proliferation of plasma cells, frequently arising in bone marrow

29
Q

what are the 3 forms of Plasmacytomas?

A

1) Solitary plasmacytoma
2) Extramedullary plasmacytoma
3) Multiple myeloma

30
Q

Plasmacytomas comprises nearly ____% of malignancies involving bone, excluding metastases

how many cases of Plasmacytomas are diagnosed each year?

A

50%

Over 26,000 cases annually in the US
Mean age of 65 years; rare

31
Q

T/F: a black male is 4 times as likely to develop Plasmacytomas than a caucasian female

A

TRUE

2:1 male predilection; black males affected 2X more than white males

32
Q

what are the symptoms of Plasmacytomas?

A

A) Initially present with bone pain

B) Myelophthisic anemia may cause fatigue, susceptibility to infection, fever, petechial hemorrhage

C) Renal failure due to circulating monoclonal immunoglobulin light chains

33
Q

what causes Bence Jones protein (during multiple myeloma)?

A

Circulating monoclonal immunoglobulin light chains spill over into the urine

34
Q

what is an Amyloid?

A

Circulating monoclonal immunoglobulin light chains deposited in tissues as acellular eosinophilic material – “amyloid”

35
Q

Give the normal levels in the blood for the following compounds:

1) IgG
2) Kappa
3) Lambda
4) K/L ratio

A

1) IgG = 700-1,500
2) Kappa = 3.3-19.4
3) lambda = 7.5-26.3
4) K/L ratio = .26-1.65

36
Q

what are the histological findings for a person with Plasmacytoma/Multiple myeloma?

A

1) Monotonous sheets of atypical plasma cells
2) Varying stages of differentiation
3) IHC studies show a monoclonal light chain restriction (kappa or lambda) in lesional cells
4) Similar finding of monoclonal gammopathy on serum protein immunoelectrophoresis

37
Q

Treatment, prognosis, and survival rates for Plasmacytoma/Multiple Myeloma:

A

A) Treatment: chemotherapy (prednisone plus an alkylating agent); thalidomide; bone marrow transplant

B) Prognosis: poor to guarded

C) Overall 5 yr survival: ~ 46%

oral path 2, exam 2 (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions